CD8A and neoplasm: Specifically, up-regulated mTORC1 signaling in RAC1A159V tumor cells increases tumor cell glycolysis and glucose consumption, leading to reduced glucose availability within the TIME that can compromise the antitumor function of CD8+ T cells.